港股异动 | 中国环保科技再升27% 两日涨幅超300% 将引入潜在投资者
格隆汇9月23日丨细价股中国环保科技(00646.HK)此前交易平淡,受公司引入潜在投资者消息影响,两日放量暴涨超300%。现涨27.06%,报0.108港元,暂成交4886万港元,最新总市值3.94亿港元。

中国环保科技19日公布,公司与厚朴生物科技签订谅解备忘录,厚朴将引入潜在投资者,通过进行股权和债务投资该公司。同时,该公司与厚朴将合作开发针对内地、香港和东南亚中高收入群体的新型保健产品和服务,并可进一步考虑建立GMP标准实验室和免疫细胞诊所。潜在投资(除其他外)须待与潜在投资者签订最终协议后方可作实。
业内人士称,拟引入投资者,可以改善公司的资本状况,为公司的发展提供动力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.